Akobundu, E, Ju, J, Blatt, L and Mullins, DC (2006) Cost-of-illness studies. A review of current methods. Pharmacoeconomics 24, 869–890.
Andlin-Sobocki, P, Jönsson, B, Wittchen, HU and Olesen, J (2005) Cost of disorders of the brain in Europe. European Journal of Neurology 12, 1–27.
Chesney, E, Goodwin, GM and Fazal, S (2014) Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry 13, 153–160.
Chong, HY, Teoh, SL, Wu, DB-C, Kotirum, S, Chiou, C-F and Chaiyakunapruk, N (2016) Global economic burden of schizophrenia: a systematic review. Neuropsychiatric Disease and Treatment 12, 357–373.
Department of Health Systems Financing Health Systems and Services: World Health Organization (2009) WHO Guide to Identifying the Economic Consequences of Disease and Injury. Geneva, Switzerland: World Health Organization, pp. 18–26.
Drummond, M (1992) Cost-of-Illness studies – a major headache? Pharmacoeconomics 2, 1–4.
Fajutrao, L, Locklear, J, Priaulx, J and Heyes, A (2009) A systematic review of the evidence of the burden of bipolar disorder in Europe. Clinical Practice and Epidemiology in Mental Health 5.
Frederix, GWJ (2019) Check your checklist: the danger of over- and underestimating the quality of economic evaluations. PharmacoEconomics – Open 3, 433–435.
Gustavsson, A, Svensson, M, Jacobi, F, Allgulander, C, Alonso, J, Beghi, E, Dodel, R, Ekman, M, Faravelli, C, Fratiglioni, L, Gannon, B, Jones, DH, Jennum, P, Jordanova, A, Jonsson, L, Karampampa, K, Knapp, M, Kobelt, G, Kurth, T, Lieb, R, Linde, M, Ljungcrantz, C, Maercker, A, Melin, B, Moscarelli, M, Musayev, A, Norwood, F, Preisig, M, Pugliatti, M, Rehm, J, Salvador-Carulla, L, Schlehofer, B, Simon, R, Steinhausen, HC, Stovner, LJ, Vallat, JM, Van den Bergh, P, van Os, J, Vos, P, Xu, W, Wittchen, HU, Jonsson, B, Olesen, J and Group, CD (2011) Cost of disorders of the brain in Europe 2010. European Neuropsychopharmacology 21, 718–779.
Jin, H and Mosweu, I (2017) The societal cost of schizophrenia: a systematic review. Pharmacoeconomics 35, 25–42.
Jo, C (2014) Cost-of-illness studies: concepts, scopes, and methods. Clinical and Molecular Hepatology 20, 327–337.
Kellermeyer, L, Harnke, B and Knight, S (2018) Covidence and Rayyan. Journal of the Medical Library Association 106, 580–583.
Knapp, M and Wong, G (2020) Economics and mental health: the current scenario. World Psychiatry 19, 3–14.
Konnopka, A, Leichsenring, F, Leibing, E and Konig, HH (2009) Cost-of-illness studies and cost-effectiveness analyses in anxiety disorders: a systematic review. Journal of Affective Disorders 114, 14–31.
Luppa, M, Heinrich, S, Angermeyer, MC, Konig, HH and Riedel-Heller, SG (2007) Cost-of-illness studies of depression: a systematic review. Journal of Affective Disorders 98, 29–43.
Moher, D, Liberati, A, Tetzlaff, J, Altman, DG and Group, P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339, 1–8.
Momen, NC, Plana-Ripoll, O, Agerbo, E, Benros, ME, Børglum, AD, Christensen, MK, Dalsgaard, S, Degenhardt, L, de Jonge, P, Debost, J-CPG, Fenger-Grøn, M, Gunn, JM, Iburg, KM, Kessing, LV, Kessler, RC, Laursen, TM, Lim, CCW, Mors, O, Mortensen, PB, Musliner, KL, Nordentoft, M, Pedersen, CB, Petersen, LV, Ribe, AR, Roest, AM, Saha, S, Schork, AJ, Scott, KM, Sievert, C, Sørensen, HJ, Stedman, TJ, Vestergaard, M, Vilhjalmsson, B, Werge, T, Weye, N, Whiteford, HA, Prior, A and McGrath, JJ (2020) Association between mental disorders and subsequent medical conditions. New England Journal of Medicine 328, 1721–1731.
Plana-Ripoll, O, Pedersen, CB, Holtz, Y, Benros, ME, Dalsgaard, S, de Jonge, P, Fan, CC, Degenhardt, L, Ganna, A, Greve, AN, Gunn, J, Iburg, KM, Kessing, LV, Lee, BK, Lim, CCW, Mors, O, Nordentoft, M, Prior, A, Roest, AM, Saha, S, Schork, A, Scott, JG, Scott, KM, Stedman, T, Sorensen, HJ, Werge, T, Whiteford, HA, Laursen, TM, Agerbo, E, Kessler, RC, Mortensen, PB and McGrath, JJ (2019) Exploring comorbidity within mental disorders among a Danish national population. JAMA Psychiatry 76, 259–270.
Schardt, C, Adams, MB, Owens, T, Keitz, S and Fontelo, P (2007) Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Medical Informatics and Decision Making 7, 7–16.
Schofield, DJ, Shrestha, RN, Percival, R, Passey, ME, Callander, EJ and Kelly, SJ (2011) The personal and national costs of mental health conditions: impacts on income, taxes, government support payments due to lost labour force participation. BMC Psychiatry 11, 72.
Steel, Z, Marnane, C, Iranpour, C, Chey, T, Jackson, JW, Patel, V and Silove, D (2014) The global prevalence of common mental disorders: a systematic review and meta-analysis 1980–2013. International Journal of Epidemiology 43, 476–493.
Stuhldreher, N, Konnopka, A, Wild, B, Herzog, W, Zipfel, S, Lowe, B and Konig, HH (2012) Cost-of-illness studies and cost-effectiveness analyses in eating disorders: a systematic review. International Journal of Eating Disorders 45, 476–491.
Tarricone, R (2006) Cost-of-illness analysis. What room in health economics? Health Policy 77, 51–63.
Vigo, D, Thornicroft, G and Atun, R (2016) Estimating the true global burden of mental illness. The Lancet Psychiatry 3, 171–178.
Xu, J, Wang, J, Wimo, A and Qiu, C (2016) The economic burden of mental disorders in China, 2005–2013: implications for health policy. BMC Psychiatry 16, 137.